Chan AS et al. |
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. |
2003 |
Oncogene |
pmid:14534543
|
Lu F et al. |
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. |
2003 |
J. Virol. |
pmid:14557628
|
Siddiqui H et al. |
Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition. |
2003 |
Mol. Cell. Biol. |
pmid:14560017
|
Martin D et al. |
Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. |
2003 |
J. Biol. Chem. |
pmid:14565956
|
Zhang Q et al. |
Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. |
2003 |
Toxicol. Appl. Pharmacol. |
pmid:14575637
|
Usenko T et al. |
Transient expression of E1A and Ras oncogenes causes downregulation of c-fos gene transcription in nontransformed REF52 cells. |
2003 |
Oncogene |
pmid:14576829
|
Allison SJ and Milner J |
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. |
2003 |
Cancer Res. |
pmid:14583461
|
Chaturvedi V et al. |
Resistance to UV-induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53. |
2004 |
J. Cell. Physiol. |
pmid:14584049
|
Mai A et al. |
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. |
2003 |
J. Med. Chem. |
pmid:14584932
|
Pace BS et al. |
p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors. |
2003 |
Exp. Hematol. |
pmid:14585374
|
Shteper PJ et al. |
Role of promoter methylation in regulation of the mammalian heparanase gene. |
2003 |
Oncogene |
pmid:14586400
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Vasudevan A et al. |
Heterocyclic ketones as inhibitors of histone deacetylase. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:14592473
|
Chung YL et al. |
A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. |
2003 |
Mol. Ther. |
pmid:14599803
|
Liu A et al. |
Oligodendrocyte process outgrowth in vitro is modulated by epigenetic regulation of cytoskeletal severing proteins. |
2003 |
Glia |
pmid:14603467
|
Moreira JM et al. |
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. |
2003 |
BMC Cancer |
pmid:14606959
|
Kim MS et al. |
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. |
2003 |
Cancer Res. |
pmid:14612526
|
Miller TA et al. |
Histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14613312
|
Hitomi T et al. |
p15(INK4b) in HDAC inhibitor-induced growth arrest. |
2003 |
FEBS Lett. |
pmid:14623092
|
Hejnar J et al. |
Demethylation of host-cell DNA at the site of avian retrovirus integration. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:14623319
|
Kramps C et al. |
E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. |
2004 |
J. Biol. Chem. |
pmid:14645238
|
Wong JE et al. |
Therapeutic strategies in gastric cancer. |
2003 |
J. Clin. Oncol. |
pmid:14645406
|
Suzuki M et al. |
Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. |
2003 |
Oncogene |
pmid:14647463
|
Kim HS et al. |
Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:14651963
|
Coombes MM et al. |
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. |
2003 |
Oncogene |
pmid:14654786
|
Thelen P et al. |
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. |
2004 |
Int. J. Oncol. |
pmid:14654937
|
Shim JS et al. |
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
2004 |
Oncogene |
pmid:14661058
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Brush MH et al. |
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. |
2004 |
J. Biol. Chem. |
pmid:14670976
|
Jang ER et al. |
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. |
2004 |
Oncogene |
pmid:14676837
|
Vaisburg A et al. |
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14684344
|
Nambu Y et al. |
Transcription-coupled events associating with immunoglobulin switch region chromatin. |
2003 |
Science |
pmid:14684824
|
Obata T et al. |
Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. |
2003 |
Clin. Cancer Res. |
pmid:14695142
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Leu TH et al. |
Participation of p97Eps8 in Src-mediated transformation. |
2004 |
J. Biol. Chem. |
pmid:14699156
|
Haggarty SJ et al. |
Small molecule modulation of the human chromatid decatenation checkpoint. |
2003 |
Chem. Biol. |
pmid:14700634
|
Pagans S et al. |
Repression by TTK69 of GAGA-mediated activation occurs in the absence of TTK69 binding to DNA and solely requires the contribution of the POZ/BTB domain of TTK69. |
2004 |
J. Biol. Chem. |
pmid:14701830
|
Yan C et al. |
A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. |
2004 |
FASEB J. |
pmid:14715692
|
Sugimoto S et al. |
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. |
2004 |
Cancer Lett. |
pmid:14732229
|
Christian M et al. |
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. |
2004 |
J. Biol. Chem. |
pmid:14736873
|
Nishikawa J et al. |
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. |
2004 |
Virus Genes |
pmid:14739656
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Parekh-Olmedo H et al. |
The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:14751821
|
Lee JH et al. |
Histone deacetylase activity is required for embryonic stem cell differentiation. |
2004 |
Genesis |
pmid:14755802
|
Lemonde S et al. |
Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. |
2004 |
J. Neurochem. |
pmid:14756806
|
Hattori N et al. |
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. |
2004 |
J. Biol. Chem. |
pmid:14761969
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Takai N et al. |
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. |
2004 |
Clin. Cancer Res. |
pmid:14871994
|
Reifenberger J et al. |
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. |
2004 |
Int. J. Cancer |
pmid:14961576
|